New GHIT Funding Supports Novel Malaria, TB Treatments, Diagnostics
This article was originally published in PharmAsia News
Executive Summary
Japan's GHIT Fund has made substantial new allocations for malaria and tuberculosis diagnosis and treatment that include extensive pharma industry participation in collaborative research projects.